Low-intensity extracorporeal shock wave therapy in vasculogenic erectile dysfunction refractory to PDE5 inhibitors: a prospective study with 12- and 18-month outcomes. Arch Ital Urol Androl. 2026;98(1). doi:10.4081/aiua.2026.14707